rs749124658
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001195518.2(MICU1):c.40delG(p.Ala14LeufsTer20) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000664 in 1,612,430 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001195518.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000163 AC: 4AN: 246022Hom.: 0 AF XY: 0.00000750 AC XY: 1AN XY: 133388
GnomAD4 exome AF: 0.0000678 AC: 99AN: 1460336Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 726346
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74282
ClinVar
Submissions by phenotype
Proximal myopathy with extrapyramidal signs Pathogenic:3
Intellectual disability, mild; pyramidal syndrome; dystonia; myoclonus; sensitivo-motor axonal neuropathy; hypotonia; intestinal malrotation -
- -
Variant summary: CBARA1 (MICU1) c.40delG (p.Ala14LeufsX20) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic in ClinVar (e.g. c.355C>T (p.Arg119*), c.547C>T (p.Gln183*))The variant allele was found at a frequency of 2.5e-05 in 277426 control chromosomes (gnomAD). c.40delG has been reported in the literature in at least one compound heterozygous individual affected with Myopathy With Extrapyramidal Signs (e.g. Cherot_2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as pathogenic (n=1) or likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ala14Leufs*20) in the MICU1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MICU1 are known to be pathogenic (PMID: 24336167). This variant is present in population databases (rs749124658, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with a neurodevelopmental disorder (PMID: 28708303). ClinVar contains an entry for this variant (Variation ID: 431146). For these reasons, this variant has been classified as Pathogenic. -
Neurodevelopmental disorder Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at